Nicole Meisner-Kober is a senior investigator at the Novartis Institutes of Biomedical Research. Her research exploits chemical biology to resolve basic mechanistic questions related to RNA therapeutics, RNA silencing biology, and pathological RNA dysregulation. Currently, her group focuses on discovery of new medicines targeting RNA pathobiology in neuro¬muscular diseases. She is also interested in the biology of extracellular vesicles and mechanisms for transfer of RNA cargo between different cells and tissues.